SIRT3/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress

Jing Gao, Zhihui Feng, Xueqiang Wang, Mengqi Zeng, Jing Liu, Shujun Han, Jie Xu, Lei Chen, Ke Cao, Jiangang Long, Zongfang Li, Weili Shen, Jiankang Liu, Jing Gao, Zhihui Feng, Xueqiang Wang, Mengqi Zeng, Jing Liu, Shujun Han, Jie Xu, Lei Chen, Ke Cao, Jiangang Long, Zongfang Li, Weili Shen, Jiankang Liu

Abstract

Recent studies have revealed robust metabolic changes during cell differentiation. Mitochondria, the organelles where many vital metabolic reactions occur, may play an important role. Here, we report the involvement of SIRT3-regulated mitochondrial stress in osteoblast differentiation and bone formation. In both the osteoblast cell line MC3T3-E1 and primary calvarial osteoblasts, robust mitochondrial biogenesis and supercomplex formation were observed during differentiation, accompanied by increased ATP production and decreased mitochondrial stress. Inhibition of mitochondrial activity or an increase in mitochondrial superoxide production significantly suppressed osteoblast differentiation. During differentiation, SOD2 was specifically induced to eliminate excess mitochondrial superoxide and protein oxidation, whereas SIRT3 expression was increased to enhance SOD2 activity through deacetylation of K68. Both SOD2 and SIRT3 knockdown resulted in suppression of differentiation. Meanwhile, mice deficient in SIRT3 exhibited obvious osteopenia accompanied by osteoblast dysfunction, whereas overexpression of SOD2 or SIRT3 improved the differentiation capability of primary osteoblasts derived from SIRT3-deficient mice. These results suggest that SIRT3/SOD2 is required for regulating mitochondrial stress and plays a vital role in osteoblast differentiation and bone formation.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Increased mitochondrial oxygen consumption in osteoblast differentiation. MC3T3-E1 cells and calvaria-derived primary osteoblasts were induced to differentiate for the indicated periods of time. (a) ARS and ALP staining of differentiated cells. (b) ALP activity of cell homogenates. (c) After differentiation for 48 h, the relative mRNA levels of Runx2, Osterix, ALP, BSP, and OCN were determined by qRT-PCR. The oxygen consumption rate (OCR) of MC3T3-E1 cells at various time points was measured with an XF24 Extracellular Flux Analyzer (d) experiment program and (e) statistical analysis). Data are presented as the mean±S.E.M. from at least three independent experiments. *P<0.05, **P<0.01 versus relative control
Figure 2
Figure 2
Mitochondrial biogenesis during osteogenic differentiation. MC3T3-E1 cells were induced to differentiate for 7, 14, and 21 days. (a) ATP content, (b) mitochondrial complex activities, (c) protein levels of PGC-1α and mtTFA, and (d) mitochondrial complex subunits were tested. (e) Cells were induced to differentiate for 7 days with rotenone, and ARS and ALP staining were performed to evaluate differentiation capacity. (f) Cells were induced to differentiate for 7 days with TTFA, and ARS and ALP staining were performed. Data are presented as the mean±S.E.M. from at least three independent experiments. *P<0.05, **P<0.01 versus relative control
Figure 3
Figure 3
Elevated antioxidative capacity during osteogenic differentiation. MC3T3-E1 cells were induced to differentiate for 7, 14, and 21 days, and cellular antioxidative capacity was evaluated by testing (a) cellular ROS content, (b) total and mitochondrial carbonyl protein levels, (c) T-AOC, (d) total-SOD activity, (e) SOD2 activity, (f) SOD1 activity, (g) mRNA levels of SOD1 and SOD2, and (h) protein levels of SOD1 and SOD2. Data are presented as the mean±S.E.M. from at least three independent experiments. *P<0.05, **P<0.01 versus relative control
Figure 4
Figure 4
SOD2 is required for osteogenic differentiation. (a) MC3T3-E1 cells were induced to differentiate for 48 h with or without 10 μM FCCP, and mRNA levels of Runx2 and BSP were tested. (b) Cells were induced to differentiate for 14 days with or without 10 μM FCCP, and ARS and ALP staining was performed. (c) SOD2 protein content from cells that stably expressed SOD2 shRNA was tested by western blot. (d) Mitochondrial superoxide levels were visualized by fluorescence staining. (e) Mitochondrial biogenesis regulators and mitochondrial complex subunits were analyzed by western blot. (f) ARS and ALP staining of SOD2-knockdown cells differentiated for 7 days. (g) mRNA levels of Runx2, Osterix, ALP, and BSP from SOD2-knockdown cells differentiated for 2 days. Data are presented as the mean±S.E.M. from at least three independent experiments. *P<0.05, **P<0.01 versus relative control
Figure 5
Figure 5
SIRT3 deacetylates SOD2 to maintain mitochondrial function and osteogenic differentiation. (a) mRNA levels of sirtuin family members in MC3T3-E1 cells under differentiation conditions for 48 h. (b) SIRT3 protein expression in cells under differentiation conditions for the indicated period. (c) SOD2 acetylation and specific K68 acetylation after 7 days of differentiation was analyzed by immunoprecipitation. (d) SOD2 acetylation of primary osteoblasts from wild-type and Sirt3−/− mice after 7 days of differentiation was analyzed by immunoprecipitation. (e) SOD2 activity of SIRT3-knockdown cells. (f) Mitochondrial superoxide levels were visualized by fluorescence staining. (g) OCR analysis of SIRT3-knockdown cells. (h) mRNA levels of Runx2, Osterix, ALP, and BSP from SIRT3-knockdown cells that were differentiated for 2 days. (i) ARS and ALP staining of SIRT3-knockdown cells that were differentiated for 7 days. (j) mRNA levels of osteogenic markers in SIRT3-knockdown cells after differentiation for 2 days with or without NAC. (k) mRNA levels of osteogenic markers in SOD2-knockdown cells after differentiation for 2 days with or without NAC. Data are presented as the mean±S.E.M. from at least three independent experiments. *P<0.05, **P<0.01 versus relative control
Figure 6
Figure 6
Decreased bone mass in Sirt3−/− mice. (a) Micro-CT images of the femurs of wild-type (Sirt3+/+) and SIRT3-knockout (Sirt3−/−) mice. In the analysis of the trabecular bone and architecture, the following parameters were calculated: (b) bone volume per tissue volume (BV/TV); (c) trabecular thickness (Tb.Th); (d) trabecular number (Tb.N); (e) trabecular spacing (Tb.Sp); (f) bone surface to bone volume (BS/BV); (g) structure model index (SMI); (h) connectivity density; and (i) bone mineral content (BMC). Data are presented as the means±S.E.M.; n=6 per group. *P<0.05, **P<0.01 versus relative control
Figure 7
Figure 7
Serum and histochemical analyses of osteoblast function in Sirt3−/− mice. Serum was collected from wild-type and Sirt3−/− mice, and the levels of the following factors were analyzed: (a) bone alkaline phosphatase (BAP); (b) osteocalcin (OC); (c) procollagen type I N-terminal propeptide (P1NP); (d) parathyroid hormone (PTH); (e) calcium; (f) phosphate; (g) 25(OH)D3; (h) tartrate-resistant acid phosphatase 5b (TRACP-5b); and (i) osteoprotegerin (OPG). (j) Femur sections were prepared from wild-type and Sirt3−/− mice at 8 weeks and immunostained with an anti-Runx2 antibody and an ALP staining kit. Data are presented as the means±S.E.M.; n=6 per group. **P<0.01 versus relative control
Figure 8
Figure 8
Reestablishing the SIRT3/SOD2 axis improves primary Sirt3−/− osteoblast function. Calvaria-derived primary osteoblasts were isolated from neonatal wild-type and Sirt3−/− mice, and the (a) protein contents of SIRT3 and SOD2, (b) SOD2 activity, and (c) ROS content were analyzed. (d) ALP activity of primary osteoblasts after differentiation for 2 days. (e) SIRT3 adenovirus was applied to Sirt3−/− primary osteoblasts, and the protein contents of complexes I and III were analyzed by western blot. (f) ROS content of primary osteoblasts infected with SIRT3 adenovirus. (g) ALP activity of primary osteoblasts infected with SIRT3 adenovirus and after differentiation for 2 days. (h) ROS content of primary osteoblasts infected with SOD2 adenovirus. (i) ALP activity of primary osteoblasts infected with SOD2 adenovirus and after differentiation for 2 days. (j) ARS staining of primary osteoblasts infected with SIRT3 and SOD2 adenovirus after 7 days of differentiation. Data are presented as the mean±S.E.M. from at least three independent experiments. *P<0.05, **P<0.01 versus relative control

References

    1. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 2011; 13: 27–38.
    1. Croucher PI, McDonald MM, Martin TJ. Bone metastasis: the importance of the neighbourhood. Nat Rev Cancer 2016; 16: 373–386.
    1. Kassem M, Bianco P. Skeletal stem cells in space and time. Cell 2015; 160: 17–19.
    1. Kain KH, Popov VL, Herzog NK. Alterations in mitochondria and mtTFA in response to LPS-induced differentiation of B-cells. Bioch Biophys Acta 2000; 1494: 91–103.
    1. San Martin N, Cervera AM, Cordova C, Covarello D, McCreath KJ, Galvez BG. Mitochondria determine the differentiation potential of cardiac mesoangioblasts. Stem Cells 2011; 29: 1064–1074.
    1. Lee S, Tak E, Lee J, Rashid MA, Murphy MP, Ha J et al. Mitochondrial H2O2 generated from electron transport chain complex I stimulates muscle differentiation. Cell Res 2011; 21: 817–834.
    1. Xun Z, Lee DY, Lim J, Canaria CA, Barnebey A, Yanonne SM et al. Retinoic acid-induced differentiation increases the rate of oxygen consumption and enhances the spare respiratory capacity of mitochondria in SH-SY5Y cells. Mech Ageing Dev 2012; 133: 176–185.
    1. Del Prete A, Zaccagnino P, Di Paola M, Saltarella M, Oliveros Celis C, Nico B et al. Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radic Biol Med 2008; 44: 1443–1451.
    1. Martinez F, Kiriakidou M, Strauss JF 3rd. Structural and functional changes in mitochondria associated with trophoblast differentiation: methods to isolate enriched preparations of syncytiotrophoblast mitochondria. Endocrinology 1997; 138: 2172–2183.
    1. Tejerina S, De Pauw A, Vankoningsloo S, Houbion A, Renard P, De Longueville F et al. Mild mitochondrial uncoupling induces 3T3-L1 adipocyte de-differentiation by a PPARgamma-independent mechanism, whereas TNFalpha-induced de-differentiation is PPARgamma dependent. J Cell Sci 2009; 122(Pt 1): 145–155.
    1. Rached MT, Kode A, Xu L, Yoshikawa Y, Paik JH, Depinho RA et al. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab 2010; 11: 147–160.
    1. Arai M, Shibata Y, Pugdee K, Abiko Y, Ogata Y. Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life 2007; 59: 27–33.
    1. Przedborski S, Schon EA. Loss of ROS—a radical response. Nat Genet 1998; 18: 99–100.
    1. Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA 2008; 105: 14447–14452.
    1. Hebert AS, Dittenhafer-Reed KE, Yu W, Bailey DJ, Selen ES, Boersma MD et al. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell 2013; 49: 186–199.
    1. Dai SH, Chen T, Wang YH, Zhu J, Luo P, Rao W et al. Sirt3 protects cortical neurons against oxidative stress via regulating mitochondrial Ca2+ and mitochondrial biogenesis. Int J Mol Sci 2014; 15: 14591–14609.
    1. Chen Y, Zhang J, Lin Y, Lei Q, Guan KL, Zhao S et al. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep 2011; 12: 534–541.
    1. Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 2010; 12: 662–667.
    1. Cheng A, Yang Y, Zhou Y, Maharana C, Lu D, Peng W et al. Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges. Cell Metab 2016; 23: 128–142.
    1. Pi H, Xu S, Reiter RJ, Guo P, Zhang L, Li Y et al. SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin. Autophagy 2015; 11: 1037–1051.
    1. Tao R, Vassilopoulos A, Parisiadou L, Yan Y, Gius D. Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis. Antioxid Redox Signal 2014; 20: 1646–1654.
    1. Huh JE, Shin JH, Jang ES, Park SJ, Park DR, Ko R et al. Sirtuin 3 (SIRT3) maintains bone homeostasis by regulating AMPK-PGC-1beta axis in mice. Sci Rep 2016; 6: 22511.
    1. Martin FM, Xu X, von Lohneysen K, Gilmartin TJ, Friedman JS. SOD2 deficient erythroid cells up-regulate transferrin receptor and down-regulate mitochondrial biogenesis and metabolism. PLoS ONE 2011; 6: e16894.
    1. Piantadosi CA, Suliman HB. Redox regulation of mitochondrial biogenesis. Free Radic Biol Med 2012; 53: 2043–2053.
    1. Hildebrand T, Ruegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Engin 1997; 1: 15–23.
    1. Hale LV, Galvin RJ, Risteli J, Ma YL, Harvey AK, Yang X et al. PINP: a serum biomarker of bone formation in the rat. Bone 2007; 40: 1103–1109.
    1. Ho WP, Chen TL, Chiu WT, Tai YT, Chen RM. Nitric oxide induces osteoblast apoptosis through a mitochondria-dependent pathway. Ann NY Acad Sci 2005; 1042: 460–470.
    1. Choi EM, Suh KS, Lee YS. Liquiritigenin restores osteoblast damage through regulating oxidative stress and mitochondrial dysfunction. Phytother Res 2014; 28: 880–886.
    1. Takano H, Zou Y, Hasegawa H, Akazawa H, Nagai T, Komuro I. Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases. Antioxid Redox Signal 2003; 5: 789–794.
    1. Reczek CR, Chandel NS. ROS-dependent signal transduction. Curr Opin Cell Biol 2015; 33: 8–13.
    1. Urao N, Ushio-Fukai M. Redox regulation of stem/progenitor cells and bone marrow niche. Free Radic Biol Med 2013; 54: 26–39.
    1. Nakano Y, Addison WN, Kaartinen MT. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures. Bone 2007; 41: 549–561.
    1. Cutarelli A, Marini M, Tancredi V, D'Arcangelo G, Murdocca M, Frank C et al. Adenosine Triphosphate stimulates differentiation and mineralization in human osteoblast-like Saos-2 cells. Dev Growth Differ 2016; 58: 400–408.
    1. Brandao-Burch A, Key ML, Patel JJ, Arnett TR, Orriss IR. The P2X7 receptor is an important regulator of extracellular ATP levels. Front Endocrinol 2012; 3: 41.
    1. Chen CT, Shih YR, Kuo TK, Lee OK, Wei YH. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 2008; 26: 960–968.
    1. Botre C, Shahu A, Adkar N, Shouche Y, Ghaskadbi S, Ashma R. Superoxide dismutase 2 polymorphisms and osteoporosis in Asian Indians: a genetic association analysis. Cell Mol Biol Lett 2015; 20: 685–697.
    1. Deng FY, Lei SF, Chen XD, Tan LJ, Zhu XZ, Deng HW. An integrative study ascertained SOD2 as a susceptibility gene for osteoporosis in Chinese. J Bone Miner Res 2011; 26: 2695–2701.
    1. Kobayashi K, Nojiri H, Saita Y, Morikawa D, Ozawa Y, Watanabe K et al. Mitochondrial superoxide in osteocytes perturbs canalicular networks in the setting of age-related osteoporosis. Sci Rep 2015; 5: 9148.
    1. Santos JM, Tewari S, Goldberg AF, Kowluru RA. Mitochondrial biogenesis and the development of diabetic retinopathy. Free Radic Biol Med 2011; 51: 1849–1860.
    1. Wang Y, Nartiss Y, Steipe B, McQuibban GA, Kim PK. ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy. Autophagy 2012; 8: 1462–1476.
    1. Candas D, Li JJ. MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx. Antioxid Redox Signal 2014; 20: 1599–1617.
    1. Abdel Khalek W, Cortade F, Ollendorff V, Lapasset L, Tintignac L, Chabi B et al. SIRT3, a mitochondrial NAD(+)-dependent deacetylase, is involved in the regulation of myoblast differentiation. PLoS ONE 2014; 9: e114388.
    1. Kim H, Lee YD, Kim HJ, Lee ZH, Kim HH. SOD2 and Sirt3 control osteoclastogenesis by regulating mitochondrial ROS. J Bone Miner Res 2017; 32: 397–406.
    1. Jonason JH, O'Keefe RJ. Isolation and culture of neonatal mouse calvarial osteoblasts. Methods Mol Biol 2014; 1130: 295–305.
    1. LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992; 5: 227–231.
    1. Hao J, Shen W, Yu G, Jia H, Li X, Feng Z et al. Hydroxytyrosol promotes mitochondrial biogenesis and mitochondrial function in 3T3-L1 adipocytes. J Nutr Biochem 2010; 21: 634–644.
    1. Feng Z, Zou X, Jia H, Li X, Zhu Z, Liu X et al. Maternal docosahexaenoic acid feeding protects against impairment of learning and memory and oxidative stress in prenatally stressed rats: possible role of neuronal mitochondria metabolism. Antioxid Redox Signal 2012; 16: 275–289.
    1. Zou X, Yan C, Shi Y, Cao K, Xu J, Wang X et al. Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin. Antioxid Redox Signal 2014; 21: 1557–1570.
    1. Wang X, Li H, Zheng A, Yang L, Liu J, Chen C et al. Mitochondrial dysfunction-associated OPA1 cleavage contributes to muscle degeneration: preventative effect of hydroxytyrosol acetate. Cell Death Dis 2014; 5: e1521.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera